Swiss National Bank
ALNY icon

Swiss National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$128M Buy
393,800
+29,600
+8% +$9.65M 0.08% 227
2025
Q1
$98.3M Buy
364,200
+1,600
+0.4% +$432K 0.07% 248
2024
Q4
$85.3M Sell
362,600
-12,800
-3% -$3.01M 0.06% 292
2024
Q3
$103M Buy
375,400
+1,000
+0.3% +$275K 0.07% 264
2024
Q2
$91M Sell
374,400
-1,500
-0.4% -$365K 0.06% 270
2024
Q1
$56.2M Sell
375,900
-14,900
-4% -$2.23M 0.04% 390
2023
Q4
$74.8M Sell
390,800
-9,800
-2% -$1.88M 0.05% 315
2023
Q3
$70.9M Sell
400,600
-47,000
-11% -$8.32M 0.06% 313
2023
Q2
$85M Sell
447,600
-40,700
-8% -$7.73M 0.06% 319
2023
Q1
$97.8M Buy
488,300
+200
+0% +$40.1K 0.07% 292
2022
Q4
$116M Sell
488,100
-35,510
-7% -$8.44M 0.08% 245
2022
Q3
$105M Buy
523,610
+2,200
+0.4% +$440K 0.08% 257
2022
Q2
$76M Buy
521,410
+3,400
+0.7% +$496K 0.05% 344
2022
Q1
$84.6M Buy
518,010
+66,300
+15% +$10.8M 0.05% 361
2021
Q4
$76.6M Sell
451,710
-12,900
-3% -$2.19M 0.05% 376
2021
Q3
$87.7M Sell
464,610
-12,300
-3% -$2.32M 0.06% 329
2021
Q2
$80.8M Buy
476,910
+30,086
+7% +$5.1M 0.05% 368
2021
Q1
$63.1M Buy
446,824
+8,800
+2% +$1.24M 0.04% 431
2020
Q4
$56.9M Sell
438,024
-8,900
-2% -$1.16M 0.04% 431
2020
Q3
$65.1M Buy
446,924
+1,500
+0.3% +$218K 0.05% 346
2020
Q2
$66M Buy
445,424
+12,800
+3% +$1.9M 0.06% 332
2020
Q1
$47.1M Buy
432,624
+82,000
+23% +$8.93M 0.05% 358
2019
Q4
$40.4M Sell
350,624
-14,800
-4% -$1.7M 0.04% 431
2019
Q3
$29.4M Buy
365,424
+53,524
+17% +$4.3M 0.03% 500
2019
Q2
$22.6M Buy
311,900
+9,100
+3% +$660K 0.02% 562
2019
Q1
$28.3M Buy
302,800
+8,500
+3% +$794K 0.03% 508
2018
Q4
$21.5M Buy
294,300
+5,400
+2% +$394K 0.03% 527
2018
Q3
$25.3M Sell
288,900
-7,700
-3% -$674K 0.03% 534
2018
Q2
$29.2M Buy
296,600
+13,700
+5% +$1.35M 0.03% 509
2018
Q1
$33.7M Sell
282,900
-43,600
-13% -$5.19M 0.04% 447
2017
Q4
$41.5M Buy
326,500
+188,600
+137% +$24M 0.04% 424
2017
Q3
$16.2M Hold
137,900
0.02% 604
2017
Q2
$11M Buy
137,900
+10,200
+8% +$814K 0.01% 658
2017
Q1
$6.55M Buy
127,700
+800
+0.6% +$41K 0.01% 833
2016
Q4
$4.75M Sell
126,900
-85,900
-40% -$3.22M 0.01% 981
2016
Q3
$14.4M Sell
212,800
-2,100
-1% -$142K 0.02% 577
2016
Q2
$11.9M Buy
214,900
+16,700
+8% +$927K 0.02% 608
2016
Q1
$11.9M Buy
198,200
+59,900
+43% +$3.6M 0.02% 594
2015
Q4
$13M Buy
138,300
+3,400
+3% +$320K 0.03% 512
2015
Q3
$10.8M Buy
134,900
+13,000
+11% +$1.04M 0.03% 544
2015
Q2
$14.6M Buy
121,900
+39,100
+47% +$4.69M 0.04% 470
2015
Q1
$8.65M Buy
82,800
+11,200
+16% +$1.17M 0.02% 590
2014
Q4
$6.95M Buy
71,600
+3,700
+5% +$359K 0.03% 568
2014
Q3
$5.3M Buy
67,900
+7,100
+12% +$555K 0.02% 667
2014
Q2
$3.84M Sell
60,800
-2,700
-4% -$171K 0.01% 867
2014
Q1
$4.26M Buy
63,500
+14,400
+29% +$967K 0.02% 791
2013
Q4
$3.16M Buy
49,100
+500
+1% +$32.2K 0.01% 816
2013
Q3
$3.11M Sell
48,600
-2,200
-4% -$141K 0.01% 774
2013
Q2
$1.58M Buy
+50,800
New +$1.58M 0.01% 1131